Direkt zum Inhalt

Luber, Birgit ; Deplazes, Joëlle ; Keller, Gisela ; Walch, Axel ; Rauser, Sandra ; Eichmann, Martin ; Langer, Rupert ; Höfler, Heinz ; Hegewisch-Becker, Susanna ; Folprecht, Gunnar ; Wöll, Ewald ; Decker, Thomas ; Endlicher, Esther ; Lorenzen, Sylvie ; Fend, Falko ; Peschel, Christian ; Lordick, Florian

Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Article

Luber, Birgit, Deplazes, Joëlle, Keller, Gisela, Walch, Axel , Rauser, Sandra, Eichmann, Martin , Langer, Rupert , Höfler, Heinz, Hegewisch-Becker, Susanna, Folprecht, Gunnar , Wöll, Ewald, Decker, Thomas, Endlicher, Esther, Lorenzen, Sylvie, Fend, Falko, Peschel, Christian and Lordick, Florian (2011) Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). BMC Cancer 11 (1).



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleBMC Cancer
PublisherBIOMED CENTRAL LTD
Place of PublicationLONDON
Volume11
Number of Issue or Book Chapter1
Date2011
Date of publication19 Dec 2024 11:03
InstitutionsMedicine > Lehrstuhl für Innere Medizin I
Identification Number
ValueType
10.1186/1471-2407-11-509DOI
KeywordsGROWTH-FACTOR RECEPTOR; E-CADHERIN GENE; IN-SITU HYBRIDIZATION; COLORECTAL-CANCER; MUTATIONS PROVIDE; POOR SURVIVAL; LUNG-CANCER; EXPRESSION; ADENOCARCINOMA; EGFR;
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID64307

Export bibliographical data

Owner only: item control page

nach oben